Baron, Michelle A.
Intarcia Therapeutics (United States)
4 papers on CoChatORCID 0000-0001-7530-5069
Most cited papers
- Verified
Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes
Rosenstock, J., Kim, S. W., Baron, M. A., Camisasca, R. ‐., Cressier, F., Couturier, A., & Dejager, S. (2007) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 255
- Verified
Effects of the Dipeptidyl Peptidase-IV Inhibitor Vildagliptin on Incretin Hormones, Islet Function, and Postprandial Glycemia in Subjects With Impaired Glucose Tolerance
Rosenstock, J., Foley, J. E., Rendell, M., Landin-Olsson, M., Holst, J. J., Deacon, C. F., Rochotte, E., & Baron, M. A. (2008) · Diabetes Care
Diabetes Treatment and ManagementPancreatic function and diabetes
Cited by 153
- Verified
PRESERVE-β
Gerich, J., Raskin, P., Jean-Louis, L., Purkayastha, D., & Baron, M. A. (2005) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 116
- Verified
Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial
Ruff, C. T., Baron, M., Im, K., O’Donoghue, M. L., Fiedorek, F. T., & Sabatine, M. S. (2022) · Nature Medicine
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 102
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free